Clinical Trials Browser

Phase 2 × Has results × paricalcitol × Clear all

NCT03415854 2026-05-12

NABPLAGEMD

Phase 2 Completed

34 enrolled 11 charts

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

NCT03138720 2026-04-22

Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

Phase 2 Completed

40 enrolled 22 charts

Gastrointestinal

Resectable Pancreatic Cancer

NCT04524702 2026-01-23

Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer

Phase 2 Completed

10 enrolled 13 charts

Gastrointestinal

Pancreatic Neoplasms

NCT03331562 2022-12-27

A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer

Phase 2 Completed

24 enrolled 14 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00634582 2018-07-06

Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases

Phase 2 Terminated

2 enrolled 6 charts

Neoplasm Metastasis, Prostatic Neoplasms